Contacts, documents and full notice history are available with a subscription.
Sources Sought Expired 1 notice 1 document

Q517--Contingency Hazardous Compounding Services VHA VISN 10 VA Medical Facilities 36C25026Q0196

Solicitation 36C25026Q0196 Copied Notice ID 418fcc5fd911464dbbfc1f202287d710 Copied VETERANS AFFAIRS, DEPARTMENT OF — 250-NETWORK CONTRACT OFFICE 10 (36C250)
SAM.gov
Posted
Dec 27, 2025
Deadline
Jan 05, 2026
Set-aside
None
NAICS
621999
PSC
Q517

Summary

AI-generated · Dec 28, 2025

Provide emergency and contingency hazardous-compounding of chemotherapy medications, to be performed at a FDA 503A compliant facility and in full compliance with state and federal laws. Compounding, labeling, and beyond-use dating must follow USP 797, USP 800, and applicable Federal Law, with the work supporting treatment for veterans across VA locations in Ohio, Indiana, and Michigan, under a requirements-type contract.

This is an information-gathering market‑research request. Respondents should submit a capability statement detailing their experience and qualifications and answer six items: (1) whether they are interested in providing a quote; (2) ability to provide expedited compounding and delivery to the specified states; (3) existence of an FDA 503A compliant facility; (4) ability to comply with the VHA Directive 1108.12; (5) SB/Socio‑economic certifications (e.g., SVOSB/VOSB) and current scope of operations; and (6) ability to meet subcontracting limitations under FAR 52.219-14 and VAAR 852.219-75, including any teaming arrangements. Include a capability statement with company name, location, and point of contact, and outline your service footprint. Do not include pricing; responses are for planning purposes only and not a contract award.

The Network Contracting Office (NCO-10) is seeking to identify vendors to perform the following services, Hazardous Compounding Contingency Pharmacy Services. This is a Request for Information (RFI) to seek capable sources and request industry feedback ONLY. This notice does not constitute a commitment by the Government. Interested parties are asked to submit capability statement that clearly and convincingly identifies their ability to fulfill the requirements. Industry feedback to the information below is requested to ensure the VA has not created a defacto sole source requirement. The Government may use the responses to this RFI for information and planning purposes. VHA VISN 10 Pharmacy Operations is seeking a vendor to provide emergency and contingency compounding of hazardous chemotherapy medicine under a requirements type contract. These compounding services are necessary to provide treatment to Veterans diagnosed with specific medical conditions. The compounding must be done at a Food and Drug Administration (FDA) 503A compliant facility and meet all state and federal laws. Compounding, labeling, and beyond use dating/expiration dating will be based on USP 797, USP 800 and Federal Law. In addition to answering the below questions 1-6, respondents are also requested to provide their capability statement, including company name, address, and point of contact information. Capabilities statement shall provide a detailed overview, experience, and qualifications to perform the requirement. Question #1: Response, are you interested in providing a quote for this requirement? Yes / No (choose one) Question #2: Can your firm provide expedited compounding services and deliver the requested therapies to VA locations in Ohio, Indiana, and Michigan? Question #3: Does your firm have a FDA 503A compliant facility to perform the required compounding orders. Question #4: Can your firm comply with VHA Directive 1108.12, Management and Monitoring of Pharmaceutical Compounded Sterile Preparations, dated 11/5/2018? Question #5: Response: If your firm is a SVOSB and/or VOSB? If so, please provide a copy of SBA certification. Please provide current scope of operations and locations of service/capability: Where is your business located and where is your main scope of operations? Please provide any additional certifications regarding the socio-economic status of your company including, WOSB, EDWOSB, HUB, 8a, Small Disadvantage Business, Small Business, etc. Question #6: Response: Does your company have the ability to perform this contract while complying with the Limitations on Subcontracting rules per FAR 52.219-14, 13 CFR 125.6 and VAAR 852.219-75. If so, please briefly explain how your firm will accomplish this, include any potential teaming arrangements or subcontractors. To Note: The CO shall conduct periodic checks with the vendor to ensure that Limitations on Subcontracting compliance is maintained during the period of performance if this requirement is set-aside for any small business entities. In accordance with 13 CFR 125.6(g), Whoever violates the requirements set forth in paragraph (a) of this section shall be subject to the penalties prescribed in 15 U.S.C. 645(d), except that the fine shall be treated as the greater of $500,000 or the dollar amount spent, in excess of permitted levels, by the entity on subcontractors. A party's failure to comply with the spirit and intent of a subcontract with a similarly situated entity may be considered a basis for debarment on the grounds, including but not limited to, that the parties have violated the terms of a government contract or subcontract pursuant to far 9.406-2(b)(1)(i) (48 CFR 9.406-2(b)(1)(i)). The applicable NAICS code for this requirement is NAICS 261999 All Other Miscellaneous Ambulatory Health Care Services, with a Small Business Size Standard of $20.5 Million Dollars. The Product Service Code is Q517 Medical- Pharmacology. For informational purposes only, Wage Determinations apply to this requirement: All businesses are encouraged to respond; however, each respondent must clearly identify their business size and socio-economic category(s) in their capabilities statement. This Request for Information (RFI) is only for the purpose of identifying potential sources as part of market research. No Request for Proposal (RFP), Quote (RFQ), or Invitation for Bid (IFB) exists. Responses to this Request for Information (RFI) are not quotes, proposals, or bids on which the VA can issue any contract. This Notice is issued for information and planning purposes only and does not itself constitute an RFP, RFQ or IFB. The Government does not intend to award a contract based only on responses to this RFI. Responses to the notice will not be returned. Responders are solely responsible for all expenses associated with responding to this Request for Information (RFI). The VA will not pay for information received in response to this Request for Information. Do not submit pricing information in response to this Request for Information. Detailed capabilities statements and answers to questions 1-6 must be submitted by email to Contracting Officer Josh Kovar at Joshua.Kovar@VA.gov, in an electronic format, no later than 1:30 PM EST on January 5, 2026. As part of market research, this Request for Information / Sources Sought is to determine if there exists an adequate number of qualified interested contractors capable of providing services for this requirement.

From Sources Sought posted on Dec 27, 2025

Notice history

1
  1. Sources Sought LATEST Posted Dec 27, 2025 View

Details

Solicitation number 36C25026Q0196
Notice ID 418fcc5fd911464dbbfc1f202287d710
Notice type Sources Sought
Product / Service (PSC) Q517
NAICS 621999
Archive date Mar 06, 2026

Award Information

Awardees
0

Documents

1
View on SAM.gov

Contacts

primary
Josh Kovar

Contracting Officer

Email

Agency

VETERANS AFFAIRS, DEPARTMENT OF
VETERANS AFFAIRS, DEPARTMENT OF
250-NETWORK CONTRACT OFFICE 10 (36C250)

Place of Performance

US Department of Veterans Affairs VHA VISN 10 VA Medical Facilities
Within Ohio, Indiana, and Michigan (12)

Dates

Posted Dec 27, 2025 7 months ago
Last Updated Aug 06, 2026 2 days ago
Due Jan 05, 2026 7 months ago